tiprankstipranks
Trending News
More News >
Sarepta Therapeutics (GB:0L35)
LSE:0L35

Sarepta Therapeutics (0L35) Similar Shares

Compare
2 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Sarepta Therapeutics
$35.46
$3.56B
20.86
-72.71%
18 Buy
5 Hold
0 Sell
Strong Buy
Alkermes
$31.21
$5.05B
14.86
27.60%
6 Buy
6 Hold
0 Sell
Moderate Buy
Blueprint Medicines
$99.49
$6.42B
-6.70%
12 Buy
4 Hold
0 Sell
Strong Buy
Axsome Therapeutics
$107.22
$5.10B
38.62%
16 Buy
0 Hold
0 Sell
Strong Buy
Revolution Medicines
$39.44
$7.35B
1.15%
12 Buy
0 Hold
0 Sell
Strong Buy
Legend Biotech
$27.69
$5.71B
-40.28%
14 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GB:0L35
Sarepta Therapeutics
36.30
-94.85
-72.32%
ALKS
Alkermes
31.21
6.75
27.60%
BPMC
Blueprint Medicines
99.49
-7.15
-6.70%
AXSM
Axsome Therapeutics
107.22
29.87
38.62%
RVMD
Revolution Medicines
39.44
0.45
1.15%
LEGN
Legend Biotech
27.69
-18.68
-40.28%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis